Samid M. Farooqui

Nov 2, 2023 | mdpi.com | Fawad Chaudry |Maureen Thivierge-Southidara |Juan Carlos Molina |Samid M. Farooqui

1. IntroductionLung cancer is the second most common cancer and accounts for the highest number of cancer-related mortality [1]. In 2011, the National Lung Screening Trial (NSLT) showed a 20% decrease in lung cancer-specific mortality from screening at-risk populations using Computed Tomography (CT) scanning [2]. Since then, the screening of at-risk individuals has become the standard of care, which increased incidental findings of lung nodules requiring further evaluation and workup.